BridgeBio Oncology Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
BridgeBio Oncology Therapeutics, Inc. (BBOT) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $625.00 thousand for the 12-month period ending 2025-12-31, per its POS AM filed 2026-04-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2026-04-30
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $625.00K POS AM · filed 2026-04-30 |
| 2024-12-31 | $694.00K POS AM · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |